↓ Skip to main content

Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific

Overview of attention for article published in Frontiers in oncology, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific
Published in
Frontiers in oncology, September 2022
DOI 10.3389/fonc.2022.1009014
Pubmed ID
Authors

Brian Duggan, Declan O’Rourke, Neil Anderson, Cherith N. Reid, Joanne Watt, Hugh O’Kane, Ruth Boyd, David Curry, Mark Evans, Michael Stevenson, Mary Jo Kurth, John V. Lamont, Peter Fitzgerald, Mark W. Ruddock

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 15%
Unspecified 1 8%
Student > Bachelor 1 8%
Student > Doctoral Student 1 8%
Student > Master 1 8%
Other 1 8%
Unknown 6 46%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 8%
Unspecified 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Nursing and Health Professions 1 8%
Agricultural and Biological Sciences 1 8%
Other 0 0%
Unknown 8 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2023.
All research outputs
#8,922,452
of 26,314,361 outputs
Outputs from Frontiers in oncology
#3,563
of 22,971 outputs
Outputs of similar age
#158,140
of 441,074 outputs
Outputs of similar age from Frontiers in oncology
#220
of 1,752 outputs
Altmetric has tracked 26,314,361 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,971 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,074 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 1,752 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.